Group 1 - The report tracks stocks, industries, and sectors that are reaching new highs, indicating market trends and hotspots [1][4] - As of July 11, 2025, the distance to the 250-day new high for major indices is as follows: Shanghai Composite Index 0.00%, Shenzhen Component Index 6.95%, CSI 300 5.67%, CSI 500 4.79%, CSI 1000 2.28%, CSI 2000 0.00%, ChiNext Index 13.46%, and STAR Market 11.75% [5][24] - The sectors closest to their 250-day new highs include Power and Utilities, Steel, Comprehensive Finance, Pharmaceuticals, and Non-ferrous Metals, while Food and Beverage, Coal, Consumer Services, Automotive, and Oil and Petrochemicals are further away [8][24] Group 2 - A total of 873 stocks reached a 250-day new high in the past 20 trading days, with the most significant numbers in Basic Chemicals, Machinery, and Pharmaceuticals [2][13] - The highest proportion of new high stocks is found in Banking, Comprehensive Finance, and National Defense and Military Industry, with respective proportions of 90.48%, 40.00%, and 33.61% [13] - The manufacturing and cyclical sectors had the most new high stocks this week, with 245 and 233 stocks respectively [15] Group 3 - The report identifies 38 stocks that are considered stable new highs, including Shenghong Technology, Beijing North, and Nanhua Futures, with the most in the Manufacturing and Technology sectors [3][21] - The Manufacturing sector had the highest number of new highs, particularly in the National Defense and Military Industry, while the Technology sector saw the most in the Electronics industry [21][25]

Core Viewpoint - The market experienced a slight increase with the three major indices showing small gains, while trading volume reached a new high since March 15, indicating increased investor activity [1][2]. Market Performance - The Shanghai Composite Index rose by 0.01%, the Shenzhen Component Index increased by 0.61%, and the ChiNext Index gained 0.8% [2]. - The total trading volume in the Shanghai and Shenzhen markets was 1.71 trillion, an increase of 218 billion compared to the previous trading day [1]. Sector Performance - The rare earth permanent magnet sector saw a collective surge, with over 10 stocks, including Northern Rare Earth, hitting the daily limit [1]. - Brokerage and internet finance stocks also experienced a significant rise, with the stock of Zhina Compass reaching an all-time high [1]. - The CRO (Contract Research Organization) sector was active, highlighted by WuXi AppTec's stock hitting the daily limit [1]. - In contrast, bank stocks faced a decline in the afternoon session, with over 20 stocks dropping more than 2% [1]. Overall Market Sentiment - The market displayed a mixed sentiment with more than 2900 stocks rising, indicating a generally positive outlook despite some sector-specific declines [1].

Group 1 - The trading volume of the Shanghai and Shenzhen stock markets exceeded 1.5 trillion, an increase of approximately 200 billion compared to the same trading day of the previous period [1] - The Shanghai Composite Index rose by 0.55%, with sectors such as brokerage, rare earth permanent magnets, shipbuilding, software development, diversified finance, and CRO showing significant gains [1] - Approximately 3,400 stocks rose while 1,800 stocks declined, indicating a net outflow of main funds of about 7 billion [1] Group 2 - The banking, PCB, gaming, power equipment, and urban renewal sectors experienced weakness [1]

Group 1 - The Shanghai Composite Index's increase narrowed to within 1%, previously reaching a high of 1.27% [1] - Sectors such as rare earth permanent magnets, shipbuilding, brokerage, diversified finance, CRO, and software development showed strong performance [1] - The total trading volume in the Shanghai and Shenzhen markets was approximately 1.14 trillion, an increase of about 140 billion compared to the previous day [1] Group 2 - Approximately 2,800 stocks rose while 2,300 stocks declined, indicating a mixed market sentiment [1] - There was a net outflow of approximately 4.4 billion from major funds [1]

Group 1 - The A-share pharmaceutical sector showed strong performance in the morning session, with notable gains in CRO, biopharmaceuticals, and innovative drugs [1] - Kangchen Pharmaceutical reached the daily limit increase, while Anke Bio surged over 6% [1] - Other stocks such as Kangtai Biological, Zhifei Biological, and Ganli Pharmaceutical also experienced upward movement [1]

Group 1 - The A-share pharmaceutical sector experienced a strong upward trend in early trading, with significant gains in concepts such as CRO, recombinant proteins, and innovative drugs [1] - Companies like Medisi saw an increase of over 16%, while Bid Pharma rose more than 7%, with other stocks like Zhaoyan New Drug, Sunshine Nuohuo, and Nossger also following suit [1] - The National Development and Reform Commission announced that since the 14th Five-Year Plan, 402 new drugs have been added to the national medical insurance drug list [1]

Group 1 - The concepts of CRO, weight loss drugs, and innovative drugs are experiencing a resurgence in the market [1] - Companies such as Puris, which saw a rise of over 14%, and Jizhitang, which hit the daily limit, are leading this trend [1] - Other companies like Saily Medical, Shanghai Yizhong, Yinuosi, and Aosaikan are also witnessing significant gains [1]

Group 1 - The A-share pharmaceutical sector has collectively rebounded, with concepts such as recombinant proteins, CRO, biopharmaceuticals, and innovative drugs showing reduced declines [1] - Jinbo Bio has seen an increase of over 3%, with stocks like Shanghai Laishi, Wantai Bio, and Bid Pharma also experiencing gains [1] - Trump previously announced that drug tariffs could reach as high as 200% [1]

Truth Social just filed for its "Crypto Blue Chip ETF"And it will hold Bitcoin, ETH, SOL, XRP and CROWith a bigger CRO allocation than XRP https://t.co/K9BpseKu4a ...

Group 1 - The ChiNext Index initially increased by 1%, while the Shanghai Composite Index rose by 0.15% [1] - The large healthcare sector experienced a collective rebound, with strong performance in CRO, innovative drugs, monoclonal antibodies, and recombinant proteins [1] - Approximately 3,800 stocks in the market rose, while 1,300 stocks declined, indicating a net outflow of over 2 billion yuan from major funds [1]